PCA Proxy Supplement Filed for May 8th Annual Meeting
Ticker: PKG · Form: DEFA14A · Filed: Apr 3, 2024 · CIK: 75677
| Field | Detail |
|---|---|
| Company | Packaging Corp Of America (PKG) |
| Form Type | DEFA14A |
| Filed Date | Apr 3, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $10,000,000, $1,000,000, $650,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
Related Tickers: PCA
TL;DR
PCA dropped proxy docs for May 8th meeting - vote your shares!
AI Summary
Packaging Corporation of America (PCA) filed a supplement to its proxy statement on April 3, 2024, regarding its annual meeting of stockholders scheduled for May 8, 2024. This filing provides additional materials for the meeting, which will cover important corporate governance matters and shareholder voting decisions.
Why It Matters
This filing informs shareholders about the upcoming annual meeting and provides them with the necessary information to participate in corporate decision-making, including voting on key proposals.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) providing supplemental information for an upcoming shareholder meeting, not indicating any immediate financial or operational risks.
Key Players & Entities
- Packaging Corporation of America (company) — Registrant
- 0001193125-24-085879 (filing_id) — Accession Number
- April 3, 2024 (date) — Filing Date
- May 8, 2024 (date) — Annual Meeting Date
FAQ
What is the purpose of this DEFA14A filing?
This filing is a supplement to the proxy statement for Packaging Corporation of America's annual meeting of stockholders, providing additional materials for shareholders.
When is Packaging Corporation of America's annual meeting of stockholders scheduled to be held?
The annual meeting of stockholders is scheduled to be held on May 8, 2024.
What is the filing date of this supplement?
This supplement to the proxy statement is dated April 3, 2024.
What is the Accession Number for this SEC filing?
The Accession Number for this filing is 0001193125-24-085879.
Is this a preliminary or definitive proxy statement?
This filing is marked as 'Definitive Additional Materials' and is a supplement to a proxy statement.
Filing Stats: 869 words · 3 min read · ~3 pages · Grade level 15.1 · Accepted 2024-04-03 14:13:57
Key Financial Figures
- $10,000,000 — s lesser or greater than 12 months) was $10,000,000. The Amended Equity Plan no longer prov
- $1,000,000 — pensation paid to a covered employee to $1,000,000. Previously there was an exception to t
- $650,000 — ch non-employee director may not exceed $650,000 during any annual period. If stockhol
Filing Documents
- d820786ddefa14a.htm (DEFA14A) — 13KB
- 0001193125-24-085879.txt ( ) — 14KB
From the Filing
DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a-12 Packaging Corporation of America (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. SUPPLEMENT TO PROXY STATEMENT DATED APRIL 3, 2024 FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD MAY 8, 2024 This Supplement to Proxy Statement (this Supplement), dated April 3, 2024, is provided to the stockholders of Packaging Corporation of America (the Company) in connection with the solicitation of proxies for use at the Companys 2024 Annual Meeting of Stockholders to be held on Wednesday, May 8, 2024 at 8:30 a.m., central time, at our corporate office located at 1 N. Field Court, Lake Forest, Illinois, or at any adjournments or postponements thereof (the Annual Meeting). This Supplement supplements the definitive Proxy Statement dated March 28, 2024 (the 2024 Proxy This Supplement is being provided to add background information regarding Item No. 3, Approval of Second Amended and Restated 1999 Long-Term Equity Incentive Plan (the Amended Equity Plan). Capitalized terms used in this Supplement and not otherwise defined herein have the meanings given to them in the 2024 Proxy Statement. This Supplement does not provide all of the information that is important to your decisions in voting at the Annual Meeting. This Supplement should be read in conjunction with the 2024 Proxy Statement. Supplemental Disclosure Concerning Item No. 3 As set forth in the 2024 Proxy Statement, Item No. 3 seeks stockholder approval of the Amended Equity Plan primarily to (i) increase the number of shares of our Common Stock authorized for issuance under the plan by an additional 2,390,000 shares (subject to adjustment for changes in capitalization) and (ii) extend the term of the plan to the tenth anniversary of the date of approval of the Amended Equity Plan by the stockholders of the Company. In addition, the Amended Equity Plan removes certain provisions of the plan that were included to comply with the exception for performance-based compensation under Section 162(m) of the Internal Revenue Code, or the Code, which was repealed in December 2017 (Section 162(m) Changes). Included in the Section 162(m) Changes were the removal of annual limits on awards that an individual participant could receive. Under these limits, the maximum number of shares that may be delivered to any one participant during any one calendar-year period pursuant to Options, SARs or Full Value Awards was 500,000 for each type of award and, with respect to cash-incentive awards, the maximum amount payable to any one participant with respect to any 12-month performance period (pro rated for performance periods lesser or greater than 12 months) was $10,000,000. The Amended Equity Plan no longer provides for the award of cash incentive awards. Section 162(m) of the Code limits the annual deduction available for compensation paid to a covered employee to $1,000,000. Previously there was an exception to this annual deduction limit for qualified performance-based compensation, but the Tax Cuts and Jobs Act eliminated this exception and there are no longer any outstanding Awards that may qualify for transition relief provided under the Tax Cuts and Jobs Act. As a result, the Amended Equity Plan removes provisions previously included to allow awards to meet this qualified performance-based compensation exception, including the individual award limits, as there is no longer any potential tax benefit for a plan to retain these provisions. Accordingly, the removal of annual limits does not reflect an intention by the Company or Compensation Committee to begin granting awards under the Amended Equity Plan at or above the maximum compensation levels previously prohibited for the specified periods under the plan. The appropriate sizing of awards under the Amended Equity Plan will continue to be subject to the discretion of our Compensation Committee. The Amended Equity Plan retains a limit applicable to awards to our non-employee directors. The value of any awards made to a non-employee director, together with other compensation payable to such non-employee director may not exceed $650,000 during any annual period. If stockholders would like to review all the changes made in the Amended Equity Plan, they should refer to t